|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 01/03/2011 |
| Corporate Officer/Principal | - | 01/03/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 01/03/2011 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.03% | +4.64% | +68.08% | +141.71% | 1,148B | |
| +1.09% | +2.51% | +47.01% | +86.57% | 652B | |
| +0.93% | +1.36% | +28.40% | +103.73% | 505B | |
| +0.73% | +2.45% | +54.26% | +66.47% | 384B | |
| +3.62% | -0.59% | +69.06% | +42.55% | 348B | |
| +2.38% | +2.65% | +34.31% | +56.33% | 294B | |
| +2.26% | +0.55% | +3.92% | +27.74% | 264B | |
| +1.57% | +2.69% | +57.43% | +74.52% | 244B | |
| +1.43% | +2.74% | +36.28% | +107.65% | 197B | |
| Average | +2.28% | +1.39% | +44.30% | +78.59% | 448.57B | |
| Weighted average by Cap. | +2.91% | +1.50% | +49.63% | +92.96% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
